Grace Therapeutics, Inc. - Common Stock, par value $0.0001 per share (GRCE)

Historical Holders from Q3 2024 to Q3 2025

Symbol
GRCE on Nasdaq
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
14,054,374
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
3,706,227
Holdings value
$11,033,102
% of all portfolios
0%
Number of holders
20
Number of buys
6
Number of sells
-5
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Grace Therapeutics, Inc. - Common Stock, par value $0.0001 per share (GRCE)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Nantahala Capital Management, LLC 9.99% 0% $4,240,177 +$37,022 1,404,032 +0.88% Nantahala Capital Management, LLC 30 Jun 2025
HIRSCHMAN ORIN 9.9% +96% $3,266,276 +$1,979,201 1,322,379 +1.5% HIRSCHMAN ORIN 31 Mar 2025

Institutional Holders of Grace Therapeutics, Inc. - Common Stock, par value $0.0001 per share (GRCE)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 3,706,227 $11,033,102 -$328,360 $2.98 20
2025 Q2 3,816,908 $11,344,205 -$607,725 $2.97 20
2025 Q1 4,024,092 $9,168,718 +$4,408,642 $2.28 17
2024 Q4 2,087,877 $7,835,456 +$4,246,540 $3.74 15
2024 Q3 959,571 $2,878,713 +$2,878,713 $3 1